Navigation Links
Paul Capital Healthcare Leads Panel on Strategic Financing
Date:6/8/2008

NEW YORK and LONDON, June 9 /PRNewswire/ -- Paul Capital Healthcare today announced that London-based partner Ken Macleod, Ph.D., will moderate a panel on strategic biotechnology financing at the BioFinance and BioInnovate Europe 08 conference. Designed to familiarize participants with how to use revenue streams as a strategic approach to financing, the panel, "Feeding the Beast: Structured Revenue Financing as a Strategy for Meeting Biotechnology's Capital Needs," is scheduled for 3:00 pm BST today. The conference, which is sponsored by the Biotechnology Industry Association, will be held at the Royal College of Physicians in London.

In addition to Dr. Macleod, the panel also will include Kristian Wiggert, Partner in the London office of Morrison & Foerster, and Steven Powell, Ph.D., Chief Executive Officer of Plethora Solutions Holdings PLC. Dr. Macleod will provide an overview and case studies of royalty and structured revenue financing transactions, Mr. Wiggert will discuss the legal considerations of these transactions and Dr. Powell will speak on the strategic rationale and mechanics of his company's recent revenue interest agreement with Paul Capital Healthcare.

"Structured revenue financing and royalty monetization transactions are becoming a standard financing strategy because they provide access to non- dilutive capital under flexible terms that can be structured to meet diverse objectives," said Dr. Macleod. "Companies and institutions can structure these transactions to provide capital for near-term initiatives while retaining a substantial portion of the long-term value and upside potential of their royalty and revenue streams. This panel presentation is designed to provide participants with real-life examples of how these transactions fit into an overall financial and asset management strategy and the opportunity to learn from those with first-hand knowledge of the process."

About Paul Capital Healthcare and Paul Capital Partners

Through its funds, Paul Capital Healthcare is one of the largest dedicated healthcare investors globally, with more than $1.4 billion in equity capital commitments and debt facilities under management. Combined, the Paul Capital Healthcare funds have invested more than $940 million in the pharmaceutical, biotechnology, and medical device sectors. These investments are focused on commercial stage companies and products, and consist of investments in the form of royalties, revenue interests, debt and equity. Additional information on Paul Capital Healthcare can be found at http://www.paulcapitalhealthcare.com. Paul Capital Partners manages nearly $5 billion in equity capital commitments for its three investment platforms, which include Paul Capital Healthcare, Private Equity Secondaries and Top Tier Fund-of-Funds. The firm has offices in New York, San Francisco, Paris, London, Hong Kong, and Sao Paolo.

Contact Information:

Paul Capital Healthcare Tel: +44 (0) 20 7514 0754

Ken Macleod, Partner

Lazar Partners Tel: +1-646-871-8487

Stephanie Seiler Tel: +1-206-713-0124

Email: sseiler@lazarpartners.com


'/>"/>
SOURCE Paul Capital Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpace Releases the 2008 BioCapital(TM) Hotbed Campaign
2. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
3. CryoLife to Present at FBR Capital Markets Annual Spring Investor Conference
4. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
5. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
6. SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008
7. Record Venture Capital and Heated Deal Environment Propel Global Biotechnology Industry Forward in 2007
8. MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments
9. Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
10. Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement
11. SPO Medical Retains American Capital Ventures for Investor Relations Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... February 04, 2016 , ... Shimadzu Scientific Instruments ... host live demos and poster sessions, and present on the analysis of mycotoxins ... place March 6 to 10 at the Georgia World Congress Center in Atlanta, ...
(Date:2/4/2016)... Columbia and MENLO PARK, Calif. ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused ... announced that it will present at the 18 th ... February 8, 2016 at 10:00 a.m. EST in ... , DelMar,s president and CEO, will provide an update on ...
(Date:2/4/2016)... BEIJING , Feb. 4, 2016 Sinovac ... ), a leading provider of biopharmaceutical products in ... committee of its board of directors received on February ... 3, 2016, from a consortium comprised of PKU V-Ming ... Sinobioway Biomedicine Co., Ltd., CICC Qianhai Development ( ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
Breaking Biology Technology:
(Date:2/2/2016)... 2, 2016 Technology Enhancements Accelerate Growth of X-ray ... the digital and computed radiography markets in ... Indonesia (TIM). It provides an ... as well as regional market drivers and restraints. The ... penetration and market attractiveness, both for digital and computed ...
(Date:2/1/2016)... ( www.wocketwallet.com ) announces the launch of a new video featuring singer, ... Las Vegas , where Joey appeared at the Wocket booth to ... , where Joey appeared at the Wocket booth to meet and greet ... the Consumer Electronics Show (CES2016) in Las Vegas , ... --> --> The video is ...
(Date:1/22/2016)... 22, 2016 ... of the  "Global Behavioral Biometric Market ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ... Biometric Market 2016-2020"  report to their ... Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ...
Breaking Biology News(10 mins):